BR0309982A - Método para identificação de um ligando, pelo qual o tempo de residência no receptor é medido - Google Patents

Método para identificação de um ligando, pelo qual o tempo de residência no receptor é medido

Info

Publication number
BR0309982A
BR0309982A BR0309982-2A BR0309982A BR0309982A BR 0309982 A BR0309982 A BR 0309982A BR 0309982 A BR0309982 A BR 0309982A BR 0309982 A BR0309982 A BR 0309982A
Authority
BR
Brazil
Prior art keywords
ligand
receptor
identifying
measured
residence time
Prior art date
Application number
BR0309982-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Patrick Karl Dorr
Manoussos Perros
Anthony Graham Rickett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0211923A external-priority patent/GB0211923D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR0309982A publication Critical patent/BR0309982A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR0309982-2A 2002-05-23 2003-05-14 Método para identificação de um ligando, pelo qual o tempo de residência no receptor é medido BR0309982A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0211923A GB0211923D0 (en) 2002-05-23 2002-05-23 Method
GB0309392 2003-04-24
PCT/IB2003/002023 WO2003100427A1 (en) 2002-05-23 2003-05-14 Method for identification of a ligand whereby receptor residence time is measured

Publications (1)

Publication Number Publication Date
BR0309982A true BR0309982A (pt) 2005-03-22

Family

ID=29585818

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309982-2A BR0309982A (pt) 2002-05-23 2003-05-14 Método para identificação de um ligando, pelo qual o tempo de residência no receptor é medido

Country Status (7)

Country Link
EP (1) EP1506405A1 (ja)
JP (1) JP2005533999A (ja)
AU (1) AU2003230129A1 (ja)
BR (1) BR0309982A (ja)
CA (1) CA2485825A1 (ja)
MX (1) MXPA04011577A (ja)
WO (1) WO2003100427A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3343220B1 (en) * 2016-12-27 2020-04-08 IMEC vzw Bioparticle characterization

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001420A1 (es) * 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
AP1965A (en) * 2000-05-26 2009-03-04 Pfizer Tropane derivatives useful in therapy.

Also Published As

Publication number Publication date
AU2003230129A1 (en) 2003-12-12
CA2485825A1 (en) 2003-12-04
MXPA04011577A (es) 2005-03-07
WO2003100427A1 (en) 2003-12-04
JP2005533999A (ja) 2005-11-10
EP1506405A1 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
CY1105871T1 (el) Ινωδες συστημα με ιξωδες ελεγχομενο δι’ οξεος και χρησεις αυτου
BRPI0513237A (pt) hidrolisados de proteìna para diminuição de pressão sanguìnea
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
BRPI0501450A (pt) Composição funcional, e, artigo
BRPI0410746A (pt) compostos e composições imunossupressoras
BR0314847A (pt) Procedimento e dispositivo para a produção de biodiesel
PA8802601A1 (es) Anticuerpos para gdf8 asi como sus usos
BR0114343A (pt) Ensaio de microdisposição de alérgenos
BR9910306A (pt) Processo para produção de uma imagem de referência para tarefas de identificação de padrões
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
ATE490122T1 (de) Heckelement für ein kraftfahrzeug umfassend eine beleuchtungseinheit
BR0116332A (pt) Processo para o aumento da estabilidade
BRPI0508131A (pt) bateria tendo rótulo de a/s e método para produzir a mesma
BR0311783A (pt) Palatinose condensada e método para produzir a mesma
MX9207137A (es) Nuevos oligodesoxirribonucleotidos, que tienen una actividad anti-isquemica, y metodos para su preparacion
BR0207881A (pt) Método para a identificação de compostos para regular a massa ou a função muscular usando receptores do fator de liberação de corticotropina
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
BR0309982A (pt) Método para identificação de um ligando, pelo qual o tempo de residência no receptor é medido
BRPI0414043A (pt) tratamento de cáncer com epotilonas
BR9811643A (pt) Suplementação quìmica de osso
BRPI0716428A2 (pt) Compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de "sst" do subtipo 5 e uso destes compostos
TW200641341A (en) Lighting apparatus for biological and medical purposes
BR0312770A (pt) Detecção de microorganismos
BRPI0412850A (pt) misturas de oligossacarìdeos derivados de heparina, o respectivo preparo e as composições farmacêuticas que as contêm
BR0110603A (pt) Couro natural revestido com poliuretano e método de preparação de couro natural revestido

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.